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Abstract Autophagy is a constitutive lysosomal catabolic
pathway that degrades damaged organelles and protein
aggregates. Stem cells are characterized by self-renewal,
pluripotency, and quiescence; their long life span, limited
capacity to dilute cellular waste and spent organelles due to
quiescence, along with their requirement for remodeling
in order to differentiate, all suggest that they require
autophagy more than other cell types. Here, we review the
current literature on the role of autophagy in embryonic
and adult stem cells, including hematopoietic, mesenchy-
mal, and neuronal stem cells, highlighting the diverse and
contrasting roles autophagy plays in their biology. Fur-
thermore, we review the few studies on stem cells,
lysosomal activity, and autophagy. Novel techniques to
detect autophagy in primary cells are required to study
autophagy in different stem cell types. These will help to
elucidate the importance of autophagy in stem cells during
transplantation, a promising therapeutic approach for many
diseases.
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Introduction
Autophagy
Macroautophagy (hereafter referred to as autophagy) is a
bulk lysosomal degradation pathway involved in recycling
long-lived proteins and cytoplasmic organelles [1]. It is
negatively regulated by serine/threonine kinase mTOR
(mammalian target of rapamycin) and is a key process for
cellular growth and metabolism [2–5], with its end prod-
ucts generating macromolecules to maintain cellular
homeostasis. The process starts with the formation of
double-membraned autophagosomes, which sequester
cargo and fuse with acidic lysosomes to form autolyso-
somes, wherein the cargo is degraded by acid hydrolases to
release the end products. There are over 30 autophagy-
related (Atg) genes identified so far and these genes are
highly conserved among eukaryotes. Atg8 and Atg12
encode two ubiquitin-like proteins; Atg12 is conjugated to
Atg5 by Atg7 and Atg10, E1 and E2-like proteins,
respectively, while Atg7 and Atg3 act to conjugate Atg8/
LC3-I to phosphatidylethanolamine (LC3-IPE/LC3-II) [6].
Finally, Atg12–Atg5 and Atg8 localize to developing
autophagosomes, which after completion fuse with lyso-
somes. On induction of autophagy, the conversion of LC3-I
into LC3-II is indicative of autophagosome formation, thus
is widely used as a marker for autophagosome formation.
This pathway depends heavily on lysosomal activity and
any defect in lysosomal degradation of autophagosomes
can lead to their accumulation, impairing cell function and
possibly leading to cell death by caspase activation [7].
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As such, lysosomal inhibitors impair autophagic degrada-
tion; examples of these along with other pharmacological
and genetic modulators are presented in Table 1. Originally
viewed as a non-selective, bulk process, it is now known
that specific proteins and organelles are selected and
degraded by autophagy (selective autophagy) via LC3-
interacting adaptors such as p62 and NBR1 [8] and
autophagy receptors like Nix [9].
Several studies implicate autophagy in the cellular
response to stressors, including damaged mitochondria,
protein aggregation, tumors, hypoxia, aging, bacteria and
viral infections, therapeutic stress and nutrient starvation
[10]. Moreover, as an intracellular recycling pathway
autophagy plays a crucial role in the active elimination of
unnecessary proteins and organelles, such as those that
accumulate during the dynamic programme of stem cell
renewal, proliferation and differentiation [11–13] (Fig. 1).
It not only provides bioenergetics support for these events
but also takes care of apoptotic bodies generated during the
process.
Stem cells
Stem cells are non-specialized cells capable of differenti-
ating into many different types of mature cells while
maintaining the stem cell population through self-replica-
tion. Stem cells are long-lived and undergo lengthy periods
of quiescence. We hypothesize that these unique properties
of stem cells, namely (1) pluripotency and differentiation,
(2) self-renewal, and (3) quiescence require autophagy
(Fig. 1):
(1 and 2) The processes of differentiation and self-
renewal require a strict control of protein turnover and
lysosomal digestion of organelles. [13]. Autophagy, as a
highly inducible catabolic process, plays a pivotal role in
the attainment of precise morphology and function by
controlling protein turnover via mTOR regulation. Taking
cues from the environment and the hormones present,
autophagy specializes in the task of ‘remodeling’ stem
cells. A fast and efficient removal of sets of transcription
factors, enzymes, adhesion molecules, or released factors
Table 1 List of autophagy
modulators in stem cells
Mode of action References
Modulator
mTOR mTOR inhibition induces autophagy [13, 46, 85, 127, 88]
miR-17, 20, 93, 106 Targets SQSTM1/p62 [51–53]
PTEN A tumor suppressor, autophagy inducer
via AKT
[92, 128, 94, 118–120]
P53 A tumor suppressor, inhibition of p53 induces
autophagy
[30, 128, 65, 31, 83, 29]
DRAM Stress-induced regulator of autophagy [129]




TFEB Transcription factor EB, master transcription
factor for lysosomal biogenesis, drives
expression of autophagy and lysosomal genes
[109]
mTORC1 Phosphorylates the ULK1-mAtg13-FIP200






Autophagy inducer via mTOR inhibition/
SIRT-dependent pathway
[10, 101]
Rapamycin Autophagy inducer via mTOR inhibition [13, 113, 115, 116]
Chloroquine (CQ) Lysosomotropic agent, inhibits fusion of
lysosomes with autophagosomes
[7, 49]
3-methyladenine (3MA) Autophagy sequestration inhibitor [13, 115, 116]
LY294002 Inhibits autophagy via phosphoinositide
3-kinases
[13]
Bafilomycin A (BafA) Vacuolar ATPase inhibitor, interferes with the
autophagosome–lysosomal fusion step
[7]
E64D/pepstatin A (PepA) Inhibition of lysosomal hydrolases, blocks the
flux of autophagic pathway
[113]
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can be efficiently accomplished by autophagy, this being a
great advantage for both differentiation and renewal. (3)
Moreover, stem cells spend most of their life in the
reversibly arrested cell cycle phase (G0 phase) waiting for
cues to re-enter the cell cycle and differentiate into pro-
genitors and tissue-specific cells [14]. Autophagic turnover
of proteins and fatty acids within these quiescent cells
presumably plays a significant role in eliminating damaged
macromolecules, which could cause loss of quiescence and
cannot be diluted by transmission to progeny cells [15]. For
example, mitophagy is essential to preserve the ‘stemness’
or pluripotency of embryonic stem cells within in vitro
long-term cultures by resisting genetic and/or mitochon-
drial damage [16].
Depending on their location in the body and the type of
cells they produce, stem cells can be classified as embry-
onic stem cells (ESCs) and adult stem cells (ASCs). ASCs
include hematopoietic (HSCs), mesenchymal (MSCs) and
neuronal stem cells (NSCs). Here we briefly review the role
of autophagy in stem cell renewal, differentiation, devel-
opment and aging (summarized in Table 2), highlighting
some most recent methods available to study autophagy in
these rare populations. Finally we will address how it can
be modulated for stem cell-based gene therapy and other
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Fig. 1 a Autophagy, a lysosomal degradation pathway engulfing organelles and protein aggregates. b Autophagy is involved in maintaining and
regulating all the basic properties of stem cells like self-renewal, quiescence, differentiation, and proliferation
Table 2 Role of autophagy in development, differentiation, and
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Detection of autophagy in rare cell populations
Stem cells are a very rare population within tissues,
making them difficult to identify and therefore difficult to
study. Much effort has been made in recent years to find
molecular markers that identify these populations in dif-
ferent tissues types [17–19, 20]. Being small populations
with a combination of multiple markers required to define
them, stem cells call for more modern techniques in order
to study their autophagy levels. Existing standard methods
of autophagy detection include western blots (measuring
the ratio between LC3-I and LC3-II), electron microscopy
or immunofluorescence detection of LC3 (dispersed to
punctate localization) or lysosomal methods using
LAMP1/lysotracker (on their own or colocalized). How-
ever, it is worth noting these techniques may not
necessarily give an accurate quantification of autophagy in
the absence of lysosomal inhibitors, thus some of the data
based on these readouts may need confirmation in the
presence of such inhibitors to get an accurate picture of
autophagy levels (Klionsky 2011 Guidelines for the use
and interpretation of assays for monitoring autophagy in
higher eukaryotes). In order to use any of the available
traditional autophagy detection techniques [21] on these
rare primary stem cell populations, cells need to be sorted;
however, both flow cytometry or bead sorting stresses
cells, thereby inducing autophagy and reducing the signal
to background ratio. Although there are a few flow-
cytometry-based methods available, these have mostly
been applied to LC3-GFP transfected cells [22, 23] rather
than primary populations.
Recent advances have begun to allow the study of
autophagy in stem cell populations. Tra et al. have gener-
ated human embryonic stem cell lines stably expressing
GFP-LC3. These cells lines, known as HES3-GFP-LC3,
express both GFP and the pluripotency marker TG30 along
with markers like Oct4, TRA-181 and TRA-160, typical
characteristics of undifferentiated hESCs. When injected
into SCID mice, they differentiate into mesoderm, endo-
derm and ectoderm layers. This could prove to be a very
useful tool to investigate autophagy in hESCs and hESC
derived cell populations [24]. Furthermore for the detection
of autophagy in primary murine stem cells, transgenic mice
expressing LC3-GFP ubiquitously can be used. However,
to study autophagy levels in human stem cells, and while
avoiding the stressful and possibly autophagy-inducing
xenografting, our lab has recently developed a novel
image-cytometry-based high-throughput assay for autoph-
agy measurement in primary cell populations [25]. This
assay combines surface markers with autophagy detection.
Endogenous LC3 is detected by anti-LC3 antibody and
lysosomal content by lysosomal markers, and the quanti-
fication of their colocalization gives an accurate measure of
autophagy levels. This unique technique, combined with
lysosomal inhibitors or evidence of subsequent degradation
and recycling of cargo, could give insight into autophagic
flux in these rare human stem cell populations without
subjecting them to any sorting procedure.
Autophagy in stem cell compartments: live and let live
Embryonic stem cells (ESCs)
ESCs are pluripotent stem cells present in the early embryo
with the capacity to differentiate into the primary germ
layers: ectoderm, endoderm, and mesoderm. The role of
Atg5/Apg5 in ES cell development was first demonstrated
using null mutation of the Atg5 gene in murine ES cells
[26], with the cells showing impaired autophagosome for-
mation by electron microscopy, suggesting a block in the
autophagy pathway, and reduced bulk protein degradation.
During the autophagic process, Atg5 is conjugated to
Atg12 to form an ubiquitin protein ligase (E3) like enzyme
for Atg8-PE conjugation [27]. Beclin 1, mammalian
homologue of yeast Atg6/Vps30, is a component of the
class III phosphatidylinositol-3-OH kinase [PI(3)K] com-
plex. Studies on beclin1-/- deficient embryonic stem cells
suggest a critical role for autophagy in maintenance of
tissue homeostasis in vivo, as mice generated from these
ES cells die early in embryogenesis [28]. In the absence of
autophagy, beclin1-/- embryonic stem cells undergo p53-
dependent apoptotic cell death involving Bcl-2 family
proteins and caspase activation on exposure to UV light
[29–31], and a similar fate awaits them on serum depri-
vation but in a caspase-independent manner [32].
Moreover, both Atg5-/- and beclin1-/- murine ES cells
show a defect in embryoid cavitation during embryonic
morphogenesis; Atg5 and beclin1 are not only essential for
the clearance of dead corpses during mammalian embry-
onic morphogenesis but also for initiation of ‘‘eat-me’’
signals required for efficient removal of apoptotic cells
[33]. Pluripotent ESCs have a small number of mitochon-
dria and their maintenance relies on efficient mitophagy.
Defect in key gene Gfer (the mammalian homologue of
yeast erv1), which is involved in the mitophagy pathway,
leads to the loss of structural and functional integrity of
ESC mitochondria, affecting ESC pluripotency and sur-
vival [34]. Finally, homozygous mutation of the autophagy
gene Ambra1 also causes embryonic lethality in mice and
its functional deficiency in embryonic stem cells leads to
severe neural tube defects and accumulation of ubiquiti-
nated proteins in cells, all linked to autophagy impairment
and dysregulation. Moreover, lack of Ambra1 during
embryogenesis leads to over proliferation and increased
apoptosis in the neuroepithelium [35], emphasizing the role
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of Ambra1 in controlling cell proliferation and cell survival
during nervous system development.
More evidence of autophagy’s role in hESC differenti-
ation comes from HES3-GFP-LC3 cell lines. During their
differentiation both increased LC3 punctae and increased
accumulation of LC3-II were observed, while further acute
induction of hESC differentiation with TGF b receptor II
inhibitor led to a rapid increase in GFP-LC3 punctae. As no
increase in GFP-LC3 punctae was observed later in dif-
ferentiated hESCs, this suggests a strong connection
between early differentiation events and autophagy induc-
tion [24]. However, this inhibitor also led to mTOR
inhibition in hESCs, thus study of hESC differentiation
induced by small molecules that do not inhibit mTOR will
be necessary for deciphering and establishing the role of
autophagy in these stem cells. In general, mTOR regulates
cell growth and metabolism in response to nutrients, growth
factors, cellular energy, through modulating translation,
transcription, ribosome biogenesis, nutrient transport, and
autophagy. It is thought that the integrated outcome of
mTOR signaling leads to a coordinated cellular program, of
which autophagy is an integral part.
Interestingly though, a recent paper suggests that eva-
sion of autophagic degradation and/or low autophagy
levels may be required for embryonic stem cell mainte-
nance by allowing accumulation of midbodies. Midbodies,
organelles formed during cell division and inherited
asymmetrically by daughter cells, can be degraded through
autophagy/lysosomal pathways but were shown to accu-
mulate in ESCs and induced pluripotent stem cells, with
enrichment in the latter improving stem cell reprogram-
ming efficiency [36]. Thus, as will be a theme throughout
this review, it seems a controlled balance of autophagic
activity may be vital for ESC maintenance.
Adult stem cells: HSCs
Adult stem cells (ASCs) are self-renewing, multipotent
cells found throughout the body; they can divide to give
rise to another stem cell or a progenitor/precursor cell
(hematopoietic, mesenchymal and neural), which can fur-
ther differentiate into specialized cell types. They are rare
and their main function is to maintain cellular homeostasis.
Several labs have suggested a role for autophagy in cellular
remodeling during differentiation and development of dif-
ferent ASCs [37, 38], with the majority of data available on
its role in hematopoietic stem cells (HSCs).
A study on mice lacking ATM (ataxia-telangiectasia
mutated kinase), a molecule that is indirectly involved in
autophagy and has a direct role in DNA damage response,
shows a loss of function in HSC self-renewal. Located in
the cytoplasm, ATM acts as a sensor of ROS and can signal
via LKB1, AMPK, and TSC2 in the cytoplasm to
deactivate mTORC1, hence inducing autophagy [39].
HSCs from ATM-/- mice were profoundly depleted, with
those remaining showing high levels of reactive oxygen
species (ROS), very similar to Atg7-/- HSCs [40]. They
also show increased levels of tumor suppressors proteins
including p16INK4a and p19ARF [41]. HSCs were restored
by NAC (N-acetyl-L-cysteine) or catalase treatment, which
acted as anti-oxidants and also down regulated p16INK4a
and p19ARF. It is possible that inducing autophagy in
ATM-/- HSCs may have had a similar effect on HSC
restoration, as autophagy has a significant role in the ROS
response (a circuit possibly interrupted by ATM mutation)
and removal of ROS-damaged organelles. This could be
tested in future studies along with use of small mole-
cule inhibitors for ATM and related signaling molecules
LKB1, AMPK and TSC2. Interestingly ATM also regulates
centrosome biogenesis and thereby suppresses genome
instability and cellular transformation [42]. Midbodies
along with older centrosomes are inherited asymmetrically
by the daughter cell and selectively accumulate in stem
cells [42]. It is possible that centrosomes get degraded
along with midbodies in stem cells by autophagy and that
ATM plays a role here.
Similarly, the differentiation of HSCs into mature white
and red blood cells and the maintenance of hematopoietic
lineages are affected by the loss of autophagy. A hemato-
poietic chimeric mouse generated with Atg5-/- fetal liver
results in T lymphopenia due to enhanced CD8? T cell
apoptosis and an inability to undergo TCR-induced pro-
liferation, suggesting a crucial role of autophagy in T cell
survival and function. These mice also show reduced
numbers of thymocytes and B lymphocytes, suggesting
Atg5’s importance in homeostatic proliferation of lym-
phocytes [43]. Likewise, studies from our lab have
demonstrated that the absence of Atg7 in the hematopoietic
system (tissue-specific excision with Vav-Cre) leads to
defective removal of mitochondria in erythroid cells, with
the mice developing severe progressive anemia [44].
Furthermore Atg7 has a non-redundant role in hemato-
poietic stem cell function and myeloid proliferation [40].
The autophagy deficient hematopoietic stem and progenitor
cells (HSPCs) from Atg7-/- mice were unable to form
secondary colonies during colony-forming cell (CFC)
assays, suggesting a defect in self-renewal. The lethally
irradiated recipients of Lin-Sca?c-Kit? (LSK) cells, con-
taining the HSPCs, purified from Vav-Atg7-/- mice died
within weeks of transplantation during noncompetitive
repopulation assays, suggesting that autophagy is indis-
pensable for normal HSC function. In line with Atg5-/-
chimeras, these mice had significantly reduced lymphoid
progenitor compartments in the bone marrow (BM) and
lymphopenia. Although the mice showed an early overall
expansion of the Vav-Atg7-/- LSK compartment, the true
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HSCs (LSKCD150?CD48-) were significantly reduced.
Moreover, the expanded LSK compartment contained
increased levels of mitochondria, suggesting impaired
mitophagy, which leads to enhanced ROS production and
DNA damage triggering both apoptosis and proliferation.
The mice developed myeloproliferation and died of BM
failure by 12 weeks. We concluded that autophagy is
essential for self-renewal, proliferation and proper func-
tioning of HSCs. Similarly, a hematopoietic and endothelial-
specific knock out mouse of FIP200 (focal adhesion kinase
family-interacting protein of 200 kD) under the Tie-2 pro-
motor showed a very similar phenotype of HSC depletion,
loss of HSC reconstitution capacity, a block in erythroid
maturation and aberrant expansion of myeloid cells with
increased mitochondrial load and DNA damage [45].
FIP200 is an essential autophagy gene and the mammalian
counterpart of yeast Atg17, part of the ULK-Atg13-FIP200
complex, which regulates autophagy in mTOR controlled
manner [46]. Interestingly, Tie2-FIP200-/- mice die in
utero or shortly after birth. This early lethality observed in
the Tie-2-driven model as opposed to the Vav-driven exci-
sion of Atg7 may be explained by either (1) the fact that
Tie-2 also drives excision in endothelial cells thereby
damaging an endothelial niche indispensable for HSC
development or by (2) the different requirement/roles of
FIP200 and Atg7 in the autophagic process.
To preserve long-term regenerative capacity and main-
tain resistance to acute physiological stress, stem cells
modulate between quiescent and proliferative states. LKB1
(a tumor suppressor, Serine/threonine kinase 11) has a role
in maintaining cellular energy levels (ATP/AMP ratio),
phosphorylating AMPK in response to a decline in the
cellular ATP/AMP ratio [47, 48]. When LKB1 is knocked
out in murine HSCs, increased cell death and LC3II levels
were observed in bone marrow, thymus and spleen [49].
While levels of LC3II were not measured in the presence of
lysosomal inhibitors, making interpretation of these results
problematic, treatment with chloroquine, an autophagy
inhibitor, accelerated the death of LKB1 mutants suggest-
ing that autophagy helps to rescue HSCs in the absence of
LKB1. Autophagy may therefore act as a compensatory
mechanism during metabolic stress in LKB1 mutant HSCs.
Recent data using expression profiling suggests that
HSC commitment, proliferation, survival, and differentia-
tion are regulated by miRNAs [50, 51]. It has been shown
that miR-17, -20, -93 and -106 are expressed abundantly in
mouse and human hematopoietic progenitor cells and their
expression considerably declines during myeloid differen-
tiation [52] with a proven role in myeloid development [51,
53]. Quantitative proteomic studies revealed that these
miRNAs target and downregulate Sequestome 1 (SQSMT1).
The SQSTM1 gene encodes p62, a multifunctional signal
adaptor scaffold protein, which regulates the transport and
targeting of poly-ubiquitinated proteins destined for degra-
dation by autophagy and proteasomal pathways [54–56].
These modified proteins predominantly colocalize with late
endosomes and lysosomal markers RAB7 and LAMP1 [57],
thus p62-dependent degradation via lysosomes may have a
significant role to play in myeloid cell expansion/regulation
[52]. However, these results are in contrast with studies
showing myeloid expansion in the absence of key autophagy
genes FIP200 or Atg7 [44, 45], suggesting either a specific
quantitative or temporal restriction to autophagy’s require-
ment during certain stages of myeloid development.
Adult stem cells: MSCs
MSCs are multipotent stem cells that can differentiate into
a variety of cell types, including osteoblasts (bone cells),
chondrocytes (cartilage cells), adipocytes (fat cells),
fibroblasts and endothelial cells. A role for autophagy
protein beclin1 in MSCs was first shown in a novel path-
way-involving ERK-mediated induction of cyclin E via
beclin1 [11]. It is known that cAMP promotes differenti-
ation of mesenchymal stem cells into neuron-like cells [58]
and the inhibition (via U0126 and siRNA) of ERK kinase
MEK significantly reduced cAMP-mediated autophagy.
Activation of ERK has been associated both with induction
or inhibition of autophagy depending on the cell types
studied [59–62]. Possibly these results suggest a role for
autophagy, via cAMP induction in MSC differentiation and
in protection against neurological disorders. Moreover,
with indications that autophagy activation in MSCs helps
to support the microenvironment of developing solid
tumors [63], understanding the roles of autophagy in MSCs
may have therapeutic value.
Furthermore, loss of Atg7 and 5 in a preadipocytic
cell line resulted in reduced triglyceride accumulation,
along with reduced induction of adipocyte differentiation
markers. Pharmacological inhibition of autophagy with
3-MA also showed a similar trend, although to a reduced
extent. Interestingly, nonspecific lysosomal inhibition with
ammonium chloride and leupeptin resulted in an analogous
phenotype, demonstrating the critical role of the auto-
phagosome-lysosomal pathway in adipocyte differentiation
[37].
Adult stem cells: NSCs
A potential role for autophagy during in vitro neuronal
differentiation was demonstrated in mouse neuroblastoma
N2a cells, where retinoic acid-induced neuronal differen-
tiation showed a time-dependent increase in the LC3II/
LC3I ratio. GFP-LC3 punctae were localized to the soma
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and neuritis of the differentiated cells. Moreover, chemical
inhibition of autophagy using 3-methyladenine (3-MA) and
LY294002 and genetic inhibition via siRNA knock down
of beclin1 resulted in differentiation defects/delays.
Intriguingly, addition of rapamycin impaired cell differ-
entiation as well, indicating that perhaps neuronal
differentiation, similar to that of ESCs and HSCs above,
depends on a very delicate balance of autophagic activity
in these cells, as neither a complete inhibition nor induction
(inhibition of mTOR) of autophagy allows proper differ-
entiation of NSCs [13]. However, impact of rapamycin on
autophagy-unrelated pathways may also play a role.
Normal lysosomal function is essential for the proper
functioning of the autophagy machinery and any defect in
lysosomal function can lead to accumulation of auto-
phagosomes. Lysosomal dysfunction has been shown to
cause death in neuronal and non-neuronal cells [64]. Neural
or neuronal precursor cells (NPCs) have high expression of
p53 (a tumor suppressor) and p53 has a crucial role in both
the autophagy and apoptosis pathways [65]. Using the
lysosomal inhibitors chloroquine (CQ) and bafilomycin A1
(BafA1, a vacuolar ATPase inhibitor) in NPCs or a neural
stem cell line resulted in a time-dependent aberrant
accumulation of autophagosomes, p53 phosphorylation,
increased damage-regulatory autophagy modulator levels
(DRAM), and caspase 3-dependent cell death. shRNA
knockdown of Atg7 significantly attenuated CQ and
BafA1-induced cell death [7]. This is in contrast to most
other studies that clearly show a pro-survival role for Atg7-
mediated autophagy and it is not clear why CQ treated cells
survive better in the absence of Atg7. Furthermore recent
in vitro studies have shown increased autophagy levels
(Atg7, Becn1, LC3 and Ambra1) in mouse embryo olfac-
tory bulb stem cells during early stages of neuronal
differentiation. Ambra1 haploinsufficiency and ATG5-/-
resulted in reduced neuronal differentiation both in vivo
and in in vitro cultures. Inhibition of autophagy using
3-MA and Wortmannin reduced neuronal differentiation.
Interestingly, adding a citric acid cycle analogue methyl
pyruvate reversed the effect [66]. This study indicates a
homeostatic role for autophagy as an energy provider
during the early stages of neuronal differentiation.
Along these lines, a recent study has reported increased
levels of autophagy (punctate immunostaining patterns for
LC3 and Atg5 along with increased conversion of LC3-I to
LC3-II and reduced p62 levels) in epidermal (ESC), dermal
(DSC), and HSC when compared to control primary
immature keratinocytes, fibroblasts and neutrophils, sug-
gesting upregulation of autophagy in these stem cells.
These three stem cell types lost their capacity to self-renew
(capacity to form colonies) and differentiate when treated
with 3-MA for 24 h or when transfected with ATG5
shRNA, hence losing their ‘stemness’. Furthermore, when
autophagy was blocked, the stem cells underwent signifi-
cant etoposide-induced apoptotic cell death [67].
Interestingly, autophagy not only plays a significant role in
self-renewal and differentiation of these adult stem cells, it
also aids their survival under hostile cytotoxic environment
of damage and dysfunction.
These data in HSCs, MSCs, DSCs, and NSCs, together
suggest a vital role for the autophagic program in adult
stem cell function; a list of all the systemic knockout mice
of ATG related genes and their respective stem cell phe-
notypes can be found in Table 3 and a schematic summary
in Fig. 2.
Selective autophagy in stem cell reprogramming
and differentiation
Studies on autophagy receptors and adaptors involved in
selective autophagy of protein aggregates (aggregophagy)
and organelles (mitophagy for mitochondria, reticulophagy
for ER and ribophagy for ribosomes) in stem cells are very
few but nonetheless are interesting and intriguing. Nix
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(also known as BNIP3L) binds to LC3/GABARAP via
LIR-W35 and has a carboxyl terminal domain essential for
targeting the proteins to the outer mitochondrial membrane
[9]; recent models have Nix and BNIP3 itself acting as a
tether between mitochondria and the forming autophago-
some [68]. Nix-/- mice generated using ES cells showed
low RBC count, polychromasia, absence of early erythro-
blasts and increased reticulocytes, all pointing towards
defects in erythrocyte maturation. Removal of mitochon-
dria is key to erythrocyte maturation but Nix-/-
reticulocytes retained mitochondria both in CD71? and
CD71- RBCs [69]. Although a few of the mitochondria
were observed inside autophagosomes, the majority were
lying outside, indicating a potential defect in targeting
these mitochondria to autophagosomes; ribophagy, how-
ever, was observed to be normal. Along with reduced
mitophagy, Nix-/- RBCs had a shorter life span, increased
ROS and spontaneous caspase activation in in vitro
cultures.
Furthermore, autophagy adapters like NBR1 are
involved in selective degradation of midbody derivatives
(MBd), which, as mentioned above, accumulate in stem
cells and are lost during their differentiation. Cells stably
expressing NBR1-specific shRNAs showed increased MBd
accumulation over control cells and have increased repro-
gramming efficiency (increased iPSC colony formation)
along with enhanced pluripotency [36]. Another study
described the role of the p62 adaptor in neuronal differ-
entiation. HiB5 cells (a multipotent hippocampal stem
cell line) can differentiate into neuronal cells and enhanced
expression of p62 was observed in efficiently differentiating
HiB5 cells. Over-expression of p62 protein in HiB5 cells
resulted in increased neuronal differentiation markers like
neurofilaments and synapsin Ia. Interestingly, p62 overex-
pression also increased cell survival under serum starvation
[70]. A more recent study shows p62-based selective
autophagy is involved in myeloid cell line differentiation
via degrading PML–RARa [a fusion protein of promyelo-
cytic leukemia (PML) and the retinoic acid receptor-a
(RARa)], while inhibition of autophagy by shRNA tar-
geting essential autophagy genes (ATG1 and 5) and
pharmacological inhibition with 3-MA blocked both all-
trans retinoic acid (ATRA)-induced PML–RARa degra-
dation and consequently myeloid cell differentiation.
Knockdown of p62 impaired this degradation and over
expression of p62 increased the delivery of PML–RARa
proteins to the lysosomes [71]. Another interesting
autophagy cargo receptor is c-Cbl. Cbl family proteins are
components of ubiquitin ligation machinery involved in
degradation of phosphorylated proteins [72]. It has been
hypothesized that they also mediate the ubiquitination and
degradation of activated KIT. KIT is a tyrosine kinase
(RTK) stem cell factor receptor and has an essential role in
development of stem cells involved in hematopoiesis,
pigmentation and reproduction [73]. Experimental evi-
dences point towards the degradation of KIT via c-Cbl
requiring proteasomal and/or lysosomal pathways as inhi-
bition of lysosomal proteases suppressed the degradation of
KIT and led to accumulation of its ubiquitinated form [74].
In general, more targeted studies are needed to define the
autophagic role of autophagic receptors and adaptors in
stem cell homeostasis.
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Fig. 2 A summary model depicting implication of loss of autophagy, the symptoms and consequences observed in various in vivo and in vitro
studies in ESCs and ASCs
96 K. Phadwal et al.
123
Autophagy and lysosomal function in stem cell aging:
live or let die
Cellular senescence is characterized by cell cycle arrest,
leading to irreversible loss of proliferative potential [75]
accompanied by a decline in homeostatic and regenerative
capacity of cells [76, 77]. Although pluripotent stem cells
are long lived, a progressive decline in telomere length
with age is reported in HSCs [78] and human MSCs are
reported to be limited to only 40-50 divisions [79].
Senescence is best characterized in MSCs, with aging
MSCs classified as (1) ‘‘deteriorating MSC’’, marked by
changes in quantity and quality, impaired self-renewal,
restricted Hayflick limit and undergoing senescence
including inactivated telomerase, (2) ‘‘persisting MSC’’,
which are less prone to senescence but subject to aging,
and finally (3) ‘‘perennial MSCs’’ that escape aging
indefinitely [80].
Various stress resistance and longevity related signaling
pathways, such as FoxO3 [81], NF-jB [82], p53 [83] and
SIRT1 [84], are effective regulators of autophagic degra-
dation. While the mTOR pathway has emerged as a key
regulator of growth and proliferation in stem cells [85], it is
also involved in maintaining quiescence by repressing
mitochondrial biogenesis and reactive oxygen species
(ROS) [86]. Removal of damaged mitochondria via
autophagy (mitophagy) reduces the oxidative burden, thus
linking the mitochondrial free radical theory of aging with
longevity [87].
Further evidence is accumulating that mTOR inhibition
can slow down cellular senescence. Furthermore, impairing
autophagy by conditional deletion of Tsc1 (tuberous scle-
rosis complex protein 1, deletion leads to constitutively
active mTOR) leads to premature aging of HSCs in young
adult mice [88] and ‘aging phenotype’ characteristics,
including a relative decrease in lymphopoiesis, impaired
capacity to reconstitute the hematopoietic system and
increased expression of cellular senescence markers like
CDK inhibitors p16 (Ink4a), p19 (Arf), and p21 (Cip1).
Inhibition of mTOR by rapamycin restored HSC function,
indeed rapamycin treated HSCs showed enhanced regen-
erative capacity, decreased expression of cellular senescence
markers and significantly extended life span. The hema-
topoietic systems of both old mice and humans show a
skewed ratio between myeloid and lymphoid progeny, as
well as decreased numbers of memory B cells and naı¨ve
T cells, thus leading to immune senescence and vaccine
failure [89–91]. Enhanced production of B lymphocytes
and decreased myelogenesis could be achieved in aged
mice after rapamycin treatment accompanied by a rejuve-
nated immune response to influenza virus. Although
mTOR is a master switch implicated in a variety of cell
growth aspects, thus inhibiting mTOR may have initiated
autophagy-independent functions, this evidence is sugges-
tive that autophagy is contributing significantly to the anti-
aging effect. In line with this and as mentioned above, our
lab has shown that mice deficient for the key autophagy
molecule Atg7 have a significantly increased myeloid
population, impaired mitophagy and loss of HSC recon-
stituting capacity, all hallmarks of aging [40, 44]. The
common idiopathic anemia in elderly people could be
partly explained by declining HSC function due to lack of
autophagy in these cells.
A factor in controlling the potential lifespan of humans
is increased risk of cancer as we grow old. Cellular
senescence is generally thought to prevent tumorigenesis
and this may be particularly important in stem cells. PTEN,
which is upstream of mTOR, stimulates autophagy [92]
and inhibits senescence. A complete loss of PTEN (tumor
suppressor phosphatase and tensin homolog) elicits a pro-
senescence response thereby countering tumorigenesis
[93]. Moreover, several studies suggest that PTEN activity
is inhibited by high levels of ROS, such as those found in
aged/ autophagy-low cells [94]. PTEN loss induced cellular
senescence (PICS) may be aided by the reduced autophagy
levels. The latter result from increased PI3K signalling,
which activates mTORC1. Therefore, it can be hypothe-
sized that expression and/or activity levels of PTEN in
aging stem cells may control their proliferation capacities.
Apart from PICS, oncogen-induced senescence (OIS) is
another tumor suppressive mechanism. An induction of
autophagy was observed when senescence was induced by
retroviral-expression of oncogenic ras (H-rasV12). Ras?
senescent cells showed presence of increased autophago-
somes (more LC3II by immunoblotting) both under basal
conditions and in presence of Baf-A, when compared to
quiescent IMR90 human diploid and embryonic skin fibro-
blast cells. Further study of autophagy level kinetics in OIS
indicated that LC3II levels were upregulated during the
‘transition phase’ between an initial ‘mitotic phase’ to the
later ‘senescence phase’ of OIS induction, where the LC3II
levels progressively decreased [95]. Although our lab
observed lower autophagy in senescent cell populations, the
brief burst of autophagy seen during the ‘transition phase’
between the ‘mitotic’ and ‘senescence phase’ may be a cel-
lular homeostatic mechanism, driving increased protein
turnover and macromolecule availability to meet the
demands of cells undergoing bursts of hyperproliferative
signaling in response to mitogenic oncogene Ras; the
autophagy levels fall as soon the cells enter the senescence
phase.
Increased expression of p16ink4a, a tumor suppressor
protein, is a preprogrammed response decreasing prolifer-
ative capacities of stem cells to alleviate the increase in
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cancer risk with age [96–100], thus setting the paradigm of
balancing senescence and cancer risk as mentioned above.
Calorie restriction (CR) seems to break this paradigm and
autophagy is required for dietary restriction-mediated life
span extension [101]. Thus CR not only reduces the loss of
stem cell proliferation with age in BALB/c mice, it also
maintains low levels of p16ink4a [102] and reduces the risk
of cancer along with promoting proliferation of stem cells
in the elderly.
Figure 3 shows a schematic diagram of autophagy’s
probable role in stem cell longevity.
Lysosomes in stem cell aging
Age related increases in the oxidation of lipids and proteins
within lysosomal membranes leads to increased volume
and fragility of lysosomes, which may result in reduced
fusion of lysosomes and autophagosomes and reduced
levels of Lamp2a on lysosomal membranes. This in turn
causes defective autophagy and chaperone-mediated
autophagy [103]. In other ways, lysosomes are also a soft
target of oxidative stress, with accumulation of the aging
pigment lipofuscin and undigested materials in senescent
cells [104]. Reduced autophagy or chaperone-mediated
autophagy limits the proteolytic ability of senescent cells
and hence limits adaptability to a changing environment,
which could be very critical for a stem cell. As stem cell
age and loose their proliferation potential, the efficiency of
biological waste dilution by cell division also decreases.
With age, stem cells show increased lipofuscin-related
autofluorescence, carbonyl content and oxidative stress, as
seen in human bone marrow derived MSCs [105, 106].
While upstream signaling (PTEN, p53 etc) is key to opti-
mum induction of the autophagic pathway, the lysosomal
coordinated mTORC1 activity [107] and downstream sig-
naling involved in autophagosome/lysosomal fusion
(HDAC6, TFEB) [108, 109] also contribute to a functional
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Fig. 3 Tightrope act inhibition of mTOR via caloric restriction (CR)
or rapamycin induces autophagy. Autophagy clears away damaged
proteins and organelles like defective mitochondria, thereby decreas-
ing ROS levels and reducing genomic damage and cellular
senescence, thus playing a crucial role in enhancing stem cell
longevity. CR may also have a role in maintaining low levels of
p16ink4a, a tumor suppressor protein, thus reducing the risk of cancer
and promoting proliferation of stem cells. Oncogenesis is countered
by loss of PTEN which elicits a p53-dependent prosenescence
response to decrease tumorigenesis
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lysosomal turnover of autophagosomes that plays a critical
role in stem cell renewal, proliferation, and aging.
Role of autophagy in stem cell-based therapeutics
Stem cell transplantation is becoming a popular therapeutic
approach to treat various central nervous system (CNS)
disorders, heart failure, diabetes and osteoarthritis, cancers,
and neurodegeneration along with other age related
degenerative disorders, and this approach is yielding sig-
nificantly promising results. One of the major barriers
opposing these transplantations is poor survival of the
engrafted stem cells; therefore substantial efforts have been
directed towards increasing their endurance. As this
involves understanding the mechanisms that regulate sur-
vival and death of these stem cells, elucidating the role of
autophagy in stem cells will be critical in prolonging the
survival of engrafted stem cells. A very recent in vitro
study has shown that survival of MSCs post transplantation
in damaged myocardium can be enhanced by drugs like
atorvastatin, which activates autophagy via the AMPK/
mTOR pathway and helps cells survive through post graft
ischemic environment of hypoxia and serum deprivation
and evade apoptosis [110]. Autophagy’s role here as
energy provider clearly is an attractive strategy towards its
application during stem cell therapies in regenerative
medicine and needs to be further explored. This also points
towards the need for further research on drugs which effect
autophagy pathway (e.g., statins and chloroquine) that are
currently in use or could be envisaged to be used during
stem cell transplantation, i.e., drug repositioning.
The use of multipotent neural stem cells in ASC-based
therapies to target neurodegenerative diseases is becom-
ing increasingly popular [111, 112]. Hippocampal neural
stem cells (HCN) can differentiate into neurons, astro-
cytes, or oligodendrocytes in vitro and following grafting
in adult human brain. Transmission electron microscopy
analysis of insulin deprived dying HCN revealed auto-
phagic vacuoles containing cytoplasmic content, while
accumulation of beclin1 and LC3II was also detected. An
increase in autophagic flux was further confirmed with
lysosomal protease inhibitors E64D/PepA. Suppressing
autophagy using Atg7-siRNA in insulin-deficient HCN
cells inhibited cell death and inducing it with rapamycin
accelerated cell death [113]. However, this is in contrast
with most in vivo studies indicating that autophagy is a
cytoprotective mechanism, with autophagic vacuoles
formation merely accompanying cell death [114], there-
fore this study may have to be repeated in more
physiological settings.
Rapamycin-induced autophagy also promotes radiosen-
sitivity and differentiation of glioma initiating cells [115,
116] and a combination of radiotherapy and rapamycin is
recommended as a potential therapeutic strategy to enhance
current treatments for patients with glioblastoma, an
aggressive brain tumor. While glioma stem/progenitor cells
(GSPCs) have low autophagic activity when compared to
neural stem/progenitor cells (NSPCs) [116], low autopha-
gic activity in other cancer stem cells has also been
reported [117]. Fetal calf serum or rapamycin promoted
differentiation of GSPCs, which was accompanied by
increased autophagy, while the autophagy inhibitors 3MA
and BafA prevented serum-induced differentiation. Many
studies have shown that the loss or mutation of PTEN
occurs during malignant transformation of stem cell pro-
genitors [118–120] and reduced PTEN expression is
associated with the capability for self-renewal in cancer
stem cells [121] and a loss of autophagic activity [122].
Overexpression of PTEN promoted autophagy in GSPCs.
These results suggest that targeting autophagy through
PTEN might have potential therapeutic value in glioma
cancers.
Finally, questions arise regarding the role of autophagy
in stem cell therapeutics: could autophagy, a highly net-
worked program with the potential for clearing away
specific sets of macromolecules or as an energy provider
under hypoxic and serum deprived conditions, be increased
for therapeutic purposes, or must autophagy/cellular
metabolism be kept in check? Future research attention
should be focused towards defining this balancing act, with
the possibility of therapeutic genetic modulation of this
pathway (master switches like GATA-1 ([123], TFEB and
FOXO3), or use of pharmacological inhibitors to achieve
similar results.
Nonetheless, another imperative question is whether
autophagic-specific factors influence the ‘fate-direction’ of
these multipotent stem cells towards a specific cell lineage?
The process of reprogramming somatic cells to become
induced pluripotent stem cells (iPSCs) is one such exam-
ple. Pluripotency potential and genomic integrity or
stability are the two most important criteria for achieving
successful reprogramming of somatic cells and studies
have shown that ROS is one of the fundamental triggers in
reprogramming barriers like senescence [124]. In fact,
rapamycin augments the reprogramming of somatic cells to
iPSCs and maintains the cells in a quiescent state rather
than pushing them to senescence as the cells retain the
capacity to resume proliferation, in response to repro-
gramming-induced senescence and cell cycle arrest [125].
Also data is now available to link autophagy promoting
molecules to differentiation of hESCs, for example osteo-
blastic differentiation of hESCs is promoted by rapamycin
[24, 126]. Of course, it needs further research to ultimately
pin down this process, eventually enabling the search for
targeted small molecules to induce and inhibit autophagy.
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